AwardedPRTGoods€71,125
261A000098 - C.Central Medicamentos 2026 - 2026/0312 (-BEVACIzumab )
- Published
- Published 13 July 2026
Overview
Unidade Local de Saúde Santa Maria procured bevacizumab (anti-cancer medication) as part of its 2026 central medicines purchasing program, with a contract value of 71,125 EUR. The award was granted to CICLUM FARMA UNIPESSOAL, LDA on 30 June 2026 and the procurement is now complete.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €71,125
- Procedure
- Open
- Published
- 13 July 2026
Immune sera and immunoglobulins
Award outcome
- Awarded value
- €71,125
- Award date
- 30 June 2026
- Contract period
- — → 27 December 2026
- CICLUM FARMA UNIPESSOAL, LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
13 July 2026
Contracting authority
Unidade Local de Saúde Santa Maria, E.P.E.
Procuring entityLisboa, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.